The recent decision to launch vaccine trials in the Democratic Republic of Congo underscores the intricate challenges of combating Ebola during persistent conflict between government forces and rebel groups.
The M23 coalition, which seized Goma and Bukavu earlier in 2025, has attempted to showcase its governance capabilities by operating a parallel Ebola response in areas it controls.
In late June, rebel authorities announced that their territories had been declared Ebola‑free.
Ebola is a rare but severe viral disease, and the Bundibugyo strain is even more uncommon, with only two documented outbreaks to date.
Symptoms of Ebola can mimic those of flu or malaria, including fever, headache and fatigue, and may onset abruptly within two to 21 days after infection.
As the disease advances, patients may experience vomiting and diarrhea, potentially leading to organ failure. Transmission occurs through contact with infected bodily fluids such as blood or vomit.
Also Read
- Alan Ritchson’s ‘Motor City’ Seeks Streaming Boost After Modest Box‑Office Run
- European Parliament President Honors Siim Kallas, Architect of Estonia’s Post-Soviet Transformation
- Comcast Unveils New Xfinity Shield Security Suite for Internet Customers
- South Korea sending first container ship through Arctic route